carboplatin
Showing 1 - 25 of 1,824
Head and Neck Squamous Cell Carcinoma Trial in United States (TAK-676, Carboplatin, 5-FU)
Completed
- Head and Neck Squamous Cell Carcinoma
- TAK-676
- +8 more
-
Shreveport, Louisiana
- +3 more
Oct 3, 2023
Recurrent Ovarian Cancer, Recurrent Uterine Cancer, Metastatic Cancer Trial in Toronto (RP-6306, Carboplatin, Paclitaxel)
Not yet recruiting
- Recurrent Ovarian Cancer
- +3 more
- RP-6306
- +2 more
-
Toronto, Ontario, CanadaPrincess Margaret Cancer Centre
Oct 25, 2023
Prostate Cancer Trial in Houston (ADI-PEG 20, Cabazitaxel, Carboplatin)
Not yet recruiting
- Prostate Cancer
- ADI-PEG 20
- +2 more
-
Houston, TexasMD Anderson Cancer Center
Oct 16, 2023
Recurrent Ovarian Cancer Trial in Pittsburgh (CPI-0209, carboplatin)
Not yet recruiting
- Recurrent Ovarian Cancer
- CPI-0209
- carboplatin
-
Pittsburgh, PennsylvaniaMagee-Womens Research Institute / UPMC Magee Womens Hospital
Jul 3, 2023
Advanced Solid Tumors Trial in Netherlands, Spain (Debio 0123, Carboplatin)
Recruiting
- Advanced Solid Tumors
- Debio 0123
- Carboplatin
-
Groningen, Netherlands
- +3 more
Jan 27, 2023
Ovarian Cancer Trial in San Diego (VS-6063, Paclitaxel, Carboplatin)
Recruiting
- Ovarian Cancer
- VS-6063
- +2 more
-
San Diego, CaliforniaUniversity of California San Diego
Feb 1, 2023
Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)
Not yet recruiting
- Metastatic Triple-Negative Breast Cancer
- Trilaciclib
- +3 more
-
Charlotte, North CarolinaLevine Cancer Institute
Aug 31, 2023
Triple Negative Metastatic Breast Cancer, Advanced Ovarian Cancer, Carboplatin Trial in Belgium, Netherlands, United Kingdom
Active, not recruiting
- Triple Negative Metastatic Breast Cancer
- +3 more
- KU-0059436 (AZD2281)(PARP inhibitor)
- +3 more
-
Brussels, Belgium
- +3 more
Dec 19, 2022
NSCLC Metastatic Trial (Atezolizumab, Nab paclitaxel, Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer Metastatic
- Atezolizumab
- +5 more
- (no location specified)
Jan 18, 2023
Metastatic Breast Cancer, Triple Negative Breast Cancer, Estrogen-receptor-low Breast Cancer Trial in Carmel, Indianapolis
Not yet recruiting
- Metastatic Breast Cancer
- +2 more
- Carboplatin
- Tocilizumab
-
Carmel, Indiana
- +2 more
Apr 27, 2023
Adult Solid Tumor Trial in Chicago (Carboplatin, Laboratory Biomarker Analysis, Paclitaxel)
Active, not recruiting
- Adult Solid Neoplasm
- Carboplatin
- +4 more
-
Chicago, IllinoisUniversity of Chicago Comprehensive Cancer Center
Jan 25, 2023
Lung Cancer Trial in Tampa, Columbus (Carboplatin, Paclitaxel, AZD1775)
Active, not recruiting
- Lung Cancer
- Carboplatin
- +2 more
-
Tampa, Florida
- +1 more
Feb 2, 2023
Lung Cancer Trial in Carlsbad, Cleveland (ISIS 3521, carboplatin, paclitaxel)
Completed
- Lung Cancer
- ISIS 3521
- +2 more
-
Carlsbad, California
- +1 more
Dec 1, 2022
BRCA1 Hereditary Breast and Ovarian Cancer Syndrome Trial in Barretos (Doxorubicin, Carboplatin, Paclitaxel)
Completed
- BRCA1 Hereditary Breast and Ovarian Cancer Syndrome
- Doxorubicin
- +3 more
-
Barretos, SP, BrazilBarretos Cancer Hospital
Dec 25, 2022
Prostate Cancer Metastatic Trial (Pembrolizumab, Carboplatin, Cabazitaxel)
Not yet recruiting
- Prostate Cancer Metastatic
- Pembrolizumab
- +2 more
- (no location specified)
Sep 29, 2022
Breast Cancer Trial in Tampa (Eribulin, Carboplatin)
Completed
- Breast Cancer
- Eribulin
- Carboplatin
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Oct 28, 2022
NSCLC Trial in Pittsburgh (Tiragolumab, Atezolizumab, Pemetrexed)
Not yet recruiting
- Non-small Cell Lung Cancer
- Tiragolumab
- +3 more
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Feb 16, 2023
Prostate Adenocarcinoma, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8 Trial (Biospecimen Collection,
Not yet recruiting
- Prostate Adenocarcinoma
- +2 more
- Biospecimen Collection
- +6 more
- (no location specified)
Mar 28, 2023
Oropharynx Squamous Cell Carcinoma Trial in Ann Arbor (Nivolumab, Carboplatin, Paclitaxel)
Active, not recruiting
- Oropharynx Squamous Cell Carcinoma
- Nivolumab
- +3 more
-
Ann Arbor, MichiganUniversity of Michigan Rogel Cancer Center
Dec 20, 2022
Small Cell Lung Cancer Recurrent Trial in Madrid, Pamplona, Valencia (Debio 0123, Etoposide, Carboplatin)
Not yet recruiting
- Small Cell Lung Cancer Recurrent
- Debio 0123
- +2 more
-
Madrid, Spain
- +3 more
Apr 3, 2023
Efficacy and Safety Trial in Zhejiang (pegylated liposomal doxorubicin, paclitaxel, Carboplatin)
Active, not recruiting
- Efficacy and Safety
- pegylated liposomal doxorubicin
- +2 more
-
Zhejiang, Hangzhou, ChinaWomen's Hospital School Of Medicine Zhejiang University
Jul 14, 2022
Glioblastoma, Recurrent Glioblastoma, GBM Trial in Worldwide (SonoCloud-9 (SC9), Carboplatin, Lomustine)
Not yet recruiting
- Glioblastoma
- +2 more
- SonoCloud-9 (SC9)
- +3 more
-
Chicago, Illinois
- +7 more
Jun 5, 2023
Epithelial Ovarian Cancer, Fallopian Tube Cancer, Peritoneal Cancer Trial in Denmark, Norway, Sweden (KAND567, Carboplatin)
Recruiting
- Epithelial Ovarian Cancer
- +2 more
- KAND567
- Carboplatin
-
Odense, Denmark
- +3 more
Oct 16, 2023
NSCLC Trial in Russian Federation (Bevacizumab, Paclitaxel, Carboplatin)
Not yet recruiting
- Non-Small Cell Lung Cancer
- Bevacizumab
- +2 more
-
Arkhangel'sk, Russian Federation
- +10 more
Dec 8, 2022
Breast Cancer Trial in Shenyang (Pyrotinib, Trastuzumab, Dalpiciclib)
Not yet recruiting
- Breast Cancer
- Pyrotinib
- +7 more
-
Shenyang, Liaoning, ChinaShengjing Hospital of China Medical University
Dec 2, 2022